• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-620
Medical Device Problem Code Imprecision (1307)
Health Effect - Clinical Codes Fever (1858); Hypoglycemia (1912); Chills (2191); Shaking/Tremors (2515)
Date of Event 01/29/2023
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)96) 2023, senseonics was made aware of an incident where the user experienced a hypoglycemia event with no alert asserted by the system due to a sensor inaccuracy.
 
Additional Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Additional Manufacturer Narrative
The user reported a hypoglycemia event where the system did not alert the user.A review of the data management system (dms) confirmed the user's reported glucose values.The system did not assert the low glucose alert because the sg value did not cross the alert threshold that was set at 65 mg/dl.However, the system asserted the low glucose alert when the sg value reached 59 mg/dl.To address the user's concern with sensor inaccuracies, sensor performance was further reviewed.The review of the diagnostic upload (du) and the data available on dms confirmed the system was working within expectations.Overall, bg values fit glucose trends well, with occasional differences due to lag and calibrations entered during periods of rapid change in glucose.The user was suggested to consider enabling predictive alerts in the app so that he can be alerted before reaching a certain glucose level.The user was advised to consult his hcp to discuss this.The user acknowledged understanding all of the provided information.The user resolved the hypoglycemic incident by eating crackers and drinking flavored water.The user is currently using the system with up-to-date information.B3.Date of event updated to 29 january 2023.B4.Date of this report updated to 31 january 2023.H3.Device evaluated by manufacturer? yes.H6.Investiagtion findings updated to 213.H6.Investigation conclusions updated to 67.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Common Device Name
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key16463869
Report Number3009862700-2023-00053
Device Sequence Number17770991
Product Code QHJ
UDI-Device Identifier00817491022936
UDI-Public817491022936
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
P160048
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date02/21/2023
Device Model Number102208-620
Device Catalogue NumberFG-5902-01-001
Device Lot Number129013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/31/2023
Supplement Date Received by Manufacturer01/31/2023
Initial Report FDA Received Date03/01/2023
Supplement Report FDA Received Date04/03/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/21/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age69 YR
Patient SexMale
-
-